ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
27.90
-0.52 (-1.83%)
At close: May 15, 2026, 4:00 PM EDT
27.87
-0.03 (-0.11%)
After-hours: May 15, 2026, 4:10 PM EDT
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $1.3 billion as of May 15, 2026. Its market cap has increased by 80.87% in one year.
Market Cap
1.30B
Enterprise Value
972.08M
1-Year Change
80.87%
Ranking
Category
Stock Price
$27.90
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $1.30B, an increase of 125.66%. That is a compound annual growth rate of 42.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 1.30B | 56.28% |
| Dec 31, 2025 | 830.58M | -7.48% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bicara Therapeutics | 1.33B |
| GH Research | 1.33B |
| Biohaven | 1.32B |
| SELLAS Life Sciences Group | 1.32B |
| Wave Life Sciences | 1.30B |
| MapLight Therapeutics | 1.30B |
| Fortrea Holdings | 1.29B |
| MoonLake Immunotherapeutics | 1.28B |